Visceral Leishmaniasis Mimicking Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Systemic Lupus Erythematosus Overlap

Department of Clinical Microbiology and Infectious Diseases, Gazi University Hospital Besevler, 06500 Ankara, Turkey.
The Korean Journal of Parasitology (Impact Factor: 1.15). 06/2012; 50(2):133-6. DOI: 10.3347/kjp.2012.50.2.133
Source: PubMed


Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In addition to typical clinical findings as fever, hepatosplenomegaly, and cachexia, VL is associated with autoimmune phenomena. To date, VL mimicking or exacerbating various autoimmune diseases have been described, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and autoimmune hepatitis (AIH). Herein, we presented a patient with VL who had overlapping clinical features with SLE, AIH, as well as antimitochondrial antibody (AMA-M2) positive primary biliary cirrhosis.

Download full-text


Available from: Abdurrahman Tufan, Apr 14, 2015
  • Source
    • "Different regimens of Ambisome® have been recommended for treatment of kala-azar [12,13,14]. The regimen which is usually administered in immunocompetent pediatric patients was scheduled for our patient [14,15]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Visceral leishmaniasis or kala-azar is an endemic parasitic disease in some parts of the world which is characterized by fever, splenomegaly, and pancytopenia in most of the cases. Herein we report an 11 month-old male infant with diagnosis of kala-azar who presented with pallor, hepatosplenomegaly, failure to gain weight, and no history of fever. Surprisingly, fever started after beginning of meglumine antimoniate treatment in this patient. As far as we are aware of, this is a rare presentation of visceral leishmaniasis. Therefore, clinicians especially in endemic areas are highly recommended to include kala-azar among differential diagnosis of unexplained anemia without fever to prevent misdiagnosis of this potentially fatal, but treatable condition.
    Full-text · Article · Apr 2014 · The Korean Journal of Parasitology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intestinal parasites infections caused by a variety of worms are very common in low-income people without access to sewage and treated water. Contamination occurs in various forms and the main one is the intake of contaminated food or water and through the skin by small wounds. The host response will be different according to the place of parasite replication: intra or extracellular. Usually the musculoskeletal symptom develops within a period of a few days after the intestinal infection. And the clinical manifestations are more likely similar to those seems in Spondiloarthropathies. It is more frequent in children and adolescent, and a slight prevalence for female. Many parasites are able to bypass the host’s immune system, and parasitic disease is the prototype of chronic infection in humans. Persistent parasites have the capacity to release large quantities of antigens, inducing a variety of immunologic reactions.
    No preview · Article · Jan 2013 · Current Rheumatology Reviews
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Leishmaniasis is a vector-born chronic infectious disease caused by a group of protozoan parasites of the Leishmania genus. Whereas most immunocompetent individuals will not develop disease after Leishmania infection, immunosuppression is a well-established risk factor for disease. The most severe form is visceral leishmaniasis (VL), typically fatal if untreated. While HIV co-infection (VL-HIV) was initially mainly reported from Southern Europe, this is now emerging in other regions including East-Africa, India and Brazil. VL has also been found in a wide range of non-HIV related immune suppressive states, mainly falling under the realm of transplantation medicine, rheumatology, hematology and oncology. Clinical presentation can be atypical in immunosuppressed individuals, easily misdiagnosed or mistaken as a flare of the underlying disease. The best diagnostic approach is the combination of parasitological and serological or molecular methods. Liposomal amphotericin B is the drug of choice. Treatment failure and relapse rates are particularly high in HIV co-infection, despite initiation of antiretroviral treatment. Primary prophylaxis is not recommended but secondary prophylaxis is recommended while immunosuppressed. Cutaneous leishmaniasis can have a number of particular features in immunosuppression, especially if severe, including parasite dissemination, clinical polymorphism with atypical and often more severe clinical forms, and even visceralisation. Mucosal leishmaniasis is more common. Treatment of cutaneous and mucosal leishmaniasis can be challenging and systemic treatment is more often indicated. With globally increased travel and access to advanced medical care in developing countries, the leishmaniasis burden in immunosuppressed individuals will probably continue to rise, warranting increased awareness and enhanced surveillance systems. This article is protected by copyright. All rights reserved.
    Full-text · Article · Jan 2014 · Clinical Microbiology and Infection
Show more